Afterwards, we further examined the prognostic value of MGME1 in LGGs using three independent cohorts, including the TCGA cohort (n = 477), the Chinese Glioma Genome Atlas (CGGA) cohort (n = 170), and the GSE16011 cohort (n = 102). Here, MGME1 is linked to central nervous system cancer.